These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 38911766)

  • 1. Global Gene Expression Profiling and Bioinformatics Analysis Reveal Downregulated Biomarkers as Potential Indicators for Hepatocellular Carcinoma.
    Mestareehi A
    ACS Omega; 2024 Jun; 9(24):26075-26096. PubMed ID: 38911766
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of Protein Phosphatase Expressions on the Prognosis of Hepatocellular Carcinoma Patients.
    Mestareehi A; Abu-Farsakh N
    ACS Omega; 2024 Mar; 9(9):10299-10331. PubMed ID: 38463290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The identification of key genes and pathways in hepatocellular carcinoma by bioinformatics analysis of high-throughput data.
    Zhang C; Peng L; Zhang Y; Liu Z; Li W; Chen S; Li G
    Med Oncol; 2017 Jun; 34(6):101. PubMed ID: 28432618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Hepatocellular Carcinoma-Related Potential Genes and Pathways Through Bioinformatic-Based Analyses.
    Wan Z; Zhang X; Luo Y; Zhao B
    Genet Test Mol Biomarkers; 2019 Nov; 23(11):766-777. PubMed ID: 31633428
    [No Abstract]   [Full Text] [Related]  

  • 5. Prognostic implications of alcohol dehydrogenases in hepatocellular carcinoma.
    Liu X; Li T; Kong D; You H; Kong F; Tang R
    BMC Cancer; 2020 Dec; 20(1):1204. PubMed ID: 33287761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrative analysis of the molecular signature of target genes involved in the antitumor effects of cantharidin on hepatocellular carcinoma.
    Yan J; Gao YM; Deng XL; Wang HS; Shi GT
    BMC Cancer; 2023 Nov; 23(1):1161. PubMed ID: 38017425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of significant gene and pathways involved in HBV-related hepatocellular carcinoma by bioinformatics analysis.
    Xie S; Jiang X; Zhang J; Xie S; Hua Y; Wang R; Yang Y
    PeerJ; 2019; 7():e7408. PubMed ID: 31392101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying hub genes and dysregulated pathways in hepatocellular carcinoma.
    Jin B; Wang W; Du G; Huang GZ; Han LT; Tang ZY; Fan DG; Li J; Zhang SZ
    Eur Rev Med Pharmacol Sci; 2015 Feb; 19(4):592-601. PubMed ID: 25753876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and Analysis of Potential Key Genes Associated With Hepatocellular Carcinoma Based on Integrated Bioinformatics Methods.
    Li Z; Lin Y; Cheng B; Zhang Q; Cai Y
    Front Genet; 2021; 12():571231. PubMed ID: 33767726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening of significant biomarkers with poor prognosis in hepatocellular carcinoma via bioinformatics analysis.
    Sun Q; Liu P; Long B; Zhu Y; Liu T
    Medicine (Baltimore); 2020 Aug; 99(32):e21702. PubMed ID: 32769939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis.
    Zhou Z; Li Y; Hao H; Wang Y; Zhou Z; Wang Z; Chu X
    Cell Transplant; 2019 Dec; 28(1_suppl):76S-86S. PubMed ID: 31822116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microarray Data Mining and Preliminary Bioinformatics Analysis of Hepatitis D Virus-Associated Hepatocellular Carcinoma.
    Yu Z; Ma X; Zhang W; Chang X; An L; Niu M; Chen Y; Sun C; Yang Y
    Biomed Res Int; 2021; 2021():1093702. PubMed ID: 33564675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioinformatics Analysis of Candidate Genes and Pathways Related to Hepatocellular Carcinoma in China: A Study Based on Public Databases.
    Zhang P; Feng J; Wu X; Chu W; Zhang Y; Li P
    Pathol Oncol Res; 2021; 27():588532. PubMed ID: 34257537
    [No Abstract]   [Full Text] [Related]  

  • 14. Quantitative phosphoproteomics reveals molecular pathway network alterations in human early-stage primary hepatic carcinomas: potential for 3P medical approach.
    Zhang Y; Li N; Yang L; Jia W; Li Z; Shao Q; Zhan X
    EPMA J; 2023 Sep; 14(3):477-502. PubMed ID: 37605650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bioinformatics analysis of core differentially expressed genes in hepatitis B virus-related hepatocellular carcinoma].
    Yu Y; Cheng J; Mei CZ; Dai YZ
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2022 Nov; 34(5):507-513. PubMed ID: 36464255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systems Network Pharmacology-Based Prediction and Analysis of Potential Targets and Pharmacological Mechanism of
    Hu Y; Yang L; Lu Y; Wang Y; Jiang J; Liu Y; Cao Q
    Evid Based Complement Alternat Med; 2022; 2022():2116006. PubMed ID: 36193154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifying hepatocellular carcinoma-related hub genes by bioinformatics analysis and CYP2C8 is a potential prognostic biomarker.
    Li C; Zhou D; Jiang X; Liu M; Tang H; Mei Z
    Gene; 2019 May; 698():9-18. PubMed ID: 30825595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of 40S ribosomal protein S8 as a novel biomarker for alcohol‑associated hepatocellular carcinoma using weighted gene co‑expression network analysis.
    Bi N; Sun Y; Lei S; Zeng Z; Zhang Y; Sun C; Yu C
    Oncol Rep; 2020 Aug; 44(2):611-627. PubMed ID: 32627011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying potential prognosis markers in hepatocellular carcinoma
    Hu X; Zhou J; Zhang Y; Zeng Y; Jie G; Wang S; Yang A; Zhang M
    Front Genet; 2022; 13():942454. PubMed ID: 35928445
    [No Abstract]   [Full Text] [Related]  

  • 20. Bioinformatics analysis reveals meaningful markers and outcome predictors in HBV-associated hepatocellular carcinoma.
    Zhang L; Makamure J; Zhao D; Liu Y; Guo X; Zheng C; Liang B
    Exp Ther Med; 2020 Jul; 20(1):427-435. PubMed ID: 32537007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.